MyMind is a life science company based in Vienna. MyMind’s first target group are children with Autism Spectrum Disorder (ASD) and then Attention Deficit Hyperactivity Disorder (ADHD). ASD is part of the personal story of the two founders as their daughter was diagnosed with ASD. ADHD often is comorbid with ASD, i.e., is diagnosed as a second disorder alongside ASD and is related to the impairment. Both groups have social behaviour issues as well as learning and concentration difficulties.
The vision of the Austrian company surgebright is to provide patients with the best bone surgery in the world in a natural way. The biotech company develops biointelligent fixation systems made of human donor bone for osteosynthesis in orthopaedics and trauma surgery. The decisive advantage of these allogenic systems is based on the body’s own biointelligence. The human bone matrix is recognized by the body, accepted and converted into its own bone.
afreeze, headquartered in Innsbruck, Austria, is a medical device company focused on treating cardiovascular disease. Ever since it was founded by a cardiologist and an engineer, the company has been committed to providing state-of-the-art solutions to support physicians and enhance patients’ lives. The coolloop cryoablation system is a powerful and precise device to combat atrial fibrillation.
Biegler is an export-oriented company with 38 employees at our site in Mauerbach near Vienna and develops and manufactures medical electronic equipment and plastic medical products for single use.
digitAAL Life GmbH is an Austrian start-up company founded in February 2020 and specializes in developing innovative digital soultions for health and care. Together with its strategic partners JOANNEUM RESEARCH and Medical University Graz digitAAL Life developed a tablet-based training game for the multimodal activation of cognitive performance, which has been already introduced to the market.
SOT Medical Systems is engaged in medical business since 30 years in Austria as well as internationally. In 1991 the company started operating in the fields of angiology, phlebology and cardiology. Since 1999, a system for the fast and reliable diagnosis of pAOD patients has been self-developed: The AngE™ System. Due to its modularity, it constitutes the ideal solution for angiologists, phlebologists, vascular surgeons and for the diagnosis of diabetic patients.